The burden of multiple myeloma in China: Trends from 1990 to 2021 and forecasts for 2050
Xuelin Dou(Peking University), Lü Jin(University of Minnesota), Xiaohui Zhang(Beijing University of Chinese Medicine), Liu Yang(Peking University), Nan Peng(Peking University), Maigeng Zhou(National Center for Chronic and Noncommunicable Disease Control and Prevention), Wen Lei(Liaoning Normal University), Jinlei Qi(National Center for Chronic and Noncommunicable Disease Control and Prevention)
Cited by 26
Related Papers
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Burden of Cardiovascular Diseases in China, 1990-2016
|JAMA Cardiology|2019|749
Association between ambient temperature and mortality risk and burden: time series study in 272 main Chinese cities
|BMJ|2018|642
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555